Neogenomics (NEO) Change in Acquisitions & Divestments (2020 - 2025)
Historic Change in Acquisitions & Divestments for Neogenomics (NEO) over the last 6 years, with Q3 2025 value amounting to $9.0 million.
- Neogenomics' Change in Acquisitions & Divestments rose 2357.54% to $9.0 million in Q3 2025 from the same period last year, while for Dec 2025 it was $20.1 million, marking a year-over-year decrease of 6279.4%. This contributed to the annual value of $20.1 million for FY2025, which is 6279.4% down from last year.
- Neogenomics' Change in Acquisitions & Divestments amounted to $9.0 million in Q3 2025, which was up 2357.54% from $3.0 million recorded in Q2 2025.
- Neogenomics' 5-year Change in Acquisitions & Divestments high stood at $40.4 million for Q1 2023, and its period low was $3.0 million during Q2 2025.
- Over the past 5 years, Neogenomics' median Change in Acquisitions & Divestments value was $20.1 million (recorded in 2024), while the average stood at $19.3 million.
- Per our database at Business Quant, Neogenomics' Change in Acquisitions & Divestments skyrocketed by 67393.89% in 2021 and then plummeted by 8528.76% in 2025.
- Over the past 5 years, Neogenomics' Change in Acquisitions & Divestments (Quarter) stood at $18.2 million in 2021, then surged by 48.64% to $27.1 million in 2022, then fell by 10.52% to $24.3 million in 2023, then plummeted by 74.72% to $6.1 million in 2024, then surged by 46.77% to $9.0 million in 2025.
- Its Change in Acquisitions & Divestments stands at $9.0 million for Q3 2025, versus $3.0 million for Q2 2025 and $8.1 million for Q1 2025.